Morgan Stanley »

Fulcrum Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2025-06-30 $2.2M 314k 6.88
2024-12-31 $7.2M 1.5M 4.70
2024-09-30 $1.3M 351k 3.57
2024-06-30 $7.7M 1.2M 6.20
2024-03-31 $11M 1.2M 9.44
2023-12-31 $8.2M 1.2M 6.75
2023-09-30 $4.0M 912k 4.44
2023-06-30 $3.6M 1.1M 3.30
2022-12-31 $8.5M 1.2M 7.28
2022-06-30 $0 1.2M 0.00
2022-03-31 $26M 1.1M 23.58
2021-06-30 $748k 72k 10.34
2020-12-31 $1.2M 99k 11.74
2020-09-30 $254k 32k 8.03
2020-06-30 $754k 41k 18.37
2020-03-31 $358k 29k 12.28
2019-12-31 $226k 14k 16.58
2019-09-30 $24k 3.5k 6.91